Dark

Check out our Level2View

BFRA
Biofrontera AG
stock NASDAQ

Inactive

Mar 4, 2022

2.67USD-9.492%(-0.28)4,951

Pre-market

0.00USD-100.000%(-2.95)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Dec 30, 2021

08:47AM EST UPDATE: Biofrontera Is No Longer Considered A Subsidiary Of Biofrontera AG Benzinga

08:45AM EST Biofrontera Announces Reduction Of Biofrontera AG Shareholding To Less Than 50% Through Warrant Exercises Benzinga

Dec 13, 2021

09:15AM EST Biofrontera AG Enrolls First Patient To Phase IIb Clinical Study Evaluating Ameluz / BF-RhodoLED For Acne Benzinga

Dec 8, 2021

09:34AM EST Biofrontera Announces Notice Of Allowance For U.S. Method-of-Use Patent On PDT-Lamp. BZ NOTE: Benzinga Reported This Patent On Dec. 2 Benzinga

Dec 6, 2021

11:43AM EST Biofrontera AG Announced Eenrollment of First Patient in Phase I Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz Benzinga

09:05AM EST Biofrontera Inc. Enrolls First Subject In Phase 1 Safety Study Evaluating Photodynamic Therapy With Three Tubes Of Ameluz Benzinga

06:55AM EST Biofrontera AG Announced Eenrollment of First Patient in Phase I Safety Study Evaluating Photodynamic Therapy with Three Tubes of Ameluz Benzinga

Dec 2, 2021

09:16AM EST Biofrontera Announces Notice Of Allowance For U.S. Patent Titled 'Illumination for Photodynamic Therapy' Benzinga

Nov 30, 2021

04:04PM EST CORRECTION: Biofrontera Inc Ticker Is 'BFRI' Benzinga

Nov 29, 2021

09:28AM EST Biofrontera Prices 2,857,143 Private Placement At $5.25/Share Benzinga

09:23AM EST Biofrontera Reaches Out-Of-Court Settlement With DUSA Pharmaceuticals, Inc.; Agrees To Pay DUSA $22.5M In Settlement Of Potential Claims Benzinga

Nov 19, 2021

08:49AM EST Biofrontera Announces Mediation Results Benzinga

Nov 17, 2021

05:02PM EST Biofrontera Q3 Net Loss 5.39.M vs Net Loss 6.456M In Same Qtr. Last Year, Sales 5.379M Benzinga

05:00PM EST Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported its financial results for the nine months ended September 30, 2021. GlobeNewswire Inc

03:59AM EST Earnings Scheduled For November 17, 2021 Benzinga

Nov 16, 2021

09:12AM EST Biofrontera Kicks Off U.S. Clinical Study Program For Ameluz Benzinga

09:01AM EST Biofrontera AG announces initiation of clinical studies GlobeNewswire Inc

Nov 9, 2021

05:46AM EST Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, will be releasing its financial results for the first nine months ended September 30, 2021 on Wednesday, November 17, 2021. GlobeNewswire Inc

Oct 22, 2021

09:56AM EDT Biofrontera Reports Received FDA Approval Of BF-RhodoLED XL Lamp Benzinga

09:55AM EDT Biofrontera AG receives FDA-approval of the GlobeNewswire Inc

Oct 1, 2021

07:45AM EDT Biofrontera Prelim. Sept Revenue Benzinga

07:44AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of September 2021. GlobeNewswire Inc

Sep 29, 2021

08:37AM EDT Biofrontera Bioscience Sponsored Study Titled 'Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp' Posted To ClinicalTrials.Gov Benzinga

Sep 8, 2021

12:14PM EDT Biofrontera Reports Preliminary Revenue For The Month Of August 2021 1.5M, Up 11% YoY Benzinga

12:10PM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of August 2021. GlobeNewswire Inc

Aug 19, 2021

11:47AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported its financial results for the six months ended June 30, 2021. GlobeNewswire Inc

Aug 12, 2021

08:55AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, will be releasing its financial results for the first six months ended June 30, 2021 on Thursday, August 19, 2021. GlobeNewswire Inc

Aug 9, 2021

09:00AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of July 2021. GlobeNewswire Inc

Jul 23, 2021

07:37AM EDT Biofrontera To Sell Photodynamic Therapy For Skin Diseases In Poland Via Supply Pact With Medac Benzinga

04:15AM EDT Biofrontera Pharma GmbH, a wholly owned subsidiary of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), and Medac Gesellschaft fr klinische Spezialprparate mbH. (Medac), signed an exclusive license and supply agreement for the marketing of both Ameluz and BF-RhodoLED in Poland. The agreement has a term of 5 years commencing with the start of sales in Poland. GlobeNewswire Inc

Jul 6, 2021

05:59PM EDT Biofrontera AG currently holds 100 % of the shares of the US-based Biofrontera Inc. GlobeNewswire Inc

10:12AM EDT Biofrontera Sees June 2021 Revs 2.626M Vs Benzinga

10:00AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of June 2021. GlobeNewswire Inc

Jun 22, 2021

12:36PM EDT Biofrontera Stock Moves Higher On Outlining Clinical Update Benzinga

09:00AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today provides an update on its clinical developments. GlobeNewswire Inc

Jun 7, 2021

10:01AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of May 2021. GlobeNewswire Inc

May 11, 2021

12:47PM EDT Earnings Scheduled For May 11, 2021 Benzinga

10:44AM EDT CORRECTION: Biofrontera Says Sales Of Co For Period From Jan. 1 To March 31, 2021 Amounted To 5.479B; Co Maintains Guidance Benzinga

10:44AM EDT Biofrontera Says Sales Of Co For Period From Jan. 1 To March 31, 2021 Amounted To 5.479B; Co Maintains Guidance Benzinga

10:41AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported its financial results for the first quarter ended March 31, 2021. GlobeNewswire Inc

10:39AM EDT Biofrontera Says Sales Of Co For Period From Jan. 1 To March 31, 2021 Amounted To 5.479B; Co Maintains Guidance Benzinga

04:14AM EDT Earnings Scheduled For May 11, 2021 Benzinga

May 6, 2021

10:13AM EDT Biofrontera Earlier Announced Prelim. Apr. Revenue 2.491M, Up From 492K YoY Benzinga

07:23AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the month of April 2021. GlobeNewswire Inc

May 3, 2021

09:40AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, will be releasing its GlobeNewswire Inc

Apr 12, 2021

01:57PM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported its consolidated results for the fiscal year ended December 31, 2020. At the same time, the Company provided an overview of current operational and clinical developments. GlobeNewswire Inc

04:36AM EDT Earnings Scheduled For April 12, 2021 Benzinga

Apr 8, 2021

10:30AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the first quarter 2021. GlobeNewswire Inc

Mar 31, 2021

10:13AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, will be releasing its financial results for the fiscal year 2020 on Monday, April 12, 2021. GlobeNewswire Inc

04:08AM EDT Biofrontera Submits Application For FDA Approval Of New BF-RhodoLED XL Lamp RTTNews

03:40AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today announced the submission for approval of a new, significantly larger red-light source for photodynamic therapy (PDT) to be used in combination with Ameluz, the BF-RhodoLED XL, to the U.S. Food and Drug Administration (FDA). GlobeNewswire Inc

Mar 26, 2021

07:28AM EDT The Daily Biotech Pulse: FDA Nod For Astellas, Seagen, Gilead Get Positive Regulatory Tidings From Europe, 3 IPOs Benzinga

Feb 26, 2021

09:20AM EST Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (Biofrontera or the Company), an international biopharmaceutical company, announces the closing of the capital increase resolved by the annual general meeting on May 28, 2020. GlobeNewswire Inc

Feb 24, 2021

08:43AM EST Biofrontera Submits Study Report Of Pharmacokinetics Study To FDA To Amend Product Info To Allow Simultaneous Use Of Three Tubes Of Ameluz Benzinga

08:37AM EST Biofrontera Submits Application To FDA To Amend Product Information Of Ameluz RTTNews

08:30AM EST Biofrontera submits study report of pharmacokinetics study to FDA GlobeNewswire Inc

07:30AM EST The Daily Biotech Pulse: Bausch Calls Truce With Icahn, Pfizer's Brain Inflammation Vaccine Gets Priority Review, BriaCell IPO Benzinga

07:17AM EST Biofrontera Raises $8.9M Via Equity Offering Benzinga

Feb 23, 2021

07:54PM EST Biofrontera AG Announces Pricing of US$8.9 Million Firm Commitment GlobeNewswire Inc

Feb 2, 2021

10:35AM EST Biofrontera AG: Ludwig Lutter appointed new Chief Financial GlobeNewswire Inc

Jan 8, 2021

09:38AM EST Biofrontera Sees FY 2020 Revs. Benzinga

09:35AM EST Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reported preliminary, unaudited revenue for the full year 2020. GlobeNewswire Inc

Jan 7, 2021

11:45AM EST Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, announces that the Cologne Higher Regional Court has granted the release of the capital increase resolved by the Annual General Meeting on May 28, 2020. GlobeNewswire Inc

Dec 7, 2020

09:15AM EST Biofrontera Enters Into A License And Supply Agreement With Galenica AB For The Marketing Of Ameluz In Scandinavia Benzinga

09:10AM EST Biofrontera Pharma GmbH, a wholly owned subsidiary of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), and Galenica AB, Malm, Sweden, today signed an exclusive license and supply agreement for the marketing of both Ameluz and BF-RhodoLED in Sweden, Norway, Denmark, Finland and Iceland. GlobeNewswire Inc

Nov 12, 2020

05:15AM EST Biofrontera Resolves Mandatory Conversion of Subordinated Mandatory Convertible Bonds Benzinga

04:27AM EST Biofrontera AG resolves mandatory conversion of subordinated GlobeNewswire Inc

Nov 11, 2020

08:40AM EST Biofrontera: Q3 Earnings Insights Benzinga

07:13AM EST Biofrontera Q3 Sales Revenue EUR 4.71 Mln Vs EUR 5.16 Mln Last Year RTTNews

07:00AM EST Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today published its results for the third quarter ended September 30, 2020. In addition, the Company provided an overview of the current business performance. GlobeNewswire Inc

04:09AM EST Earnings Scheduled For November 11, 2020 Benzinga

Nov 2, 2020

08:00AM EST Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, will be releasing its unaudited financial results for the third quarter ended September 30, 2020 on Wednesday, November 11, 2020. GlobeNewswire Inc

Oct 14, 2020

08:30AM EDT Biofrontera Receives Statement Of Reasons Of German Federal Supreme Court Regarding Reversal Of Ruling RTTNews

04:30AM EDT Biofrontera AG: Receives reasons from the Federal Court of Justice GlobeNewswire Inc

Oct 9, 2020

10:32AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today reports preliminary unaudited revenue for the third quarter of fiscal year 2020. GlobeNewswire Inc

Oct 8, 2020

11:04AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, reports the completion of the clinical phase (last subject last visit) of the pharmacokinetics study (PK study) to test the safety of photodynamic therapy (PDT) using three tubes of Ameluz at the same time. GlobeNewswire Inc

Sep 22, 2020

12:08PM EDT Biofrontera AG Announces German Federal Supreme Court Overturns Ruling Of Colgne Higher Regional Court Which Was Directed Against Co Benzinga

12:02PM EDT Biofrontera AG: German Federal Supreme Court overturns ruling of GlobeNewswire Inc

Sep 11, 2020

03:07PM EDT Mid-Afternoon Market Update: Nasdaq Drops Over 100 Points; A-Mark Precious Metals Shares Spike Higher Benzinga

12:04PM EDT Mid-Day Market Update: Zumiez Surges After Q2 Results; Amyris Shares Slide Benzinga

10:29AM EDT Biofrontera AG (BFRA) shares are rising on Friday morning trade as the biopharmaceutical company reached a mutual agreement with Wilhem K.T. Zours and Deutsche Balaton AG to resolve legal disputes. RTTNews

10:21AM EDT Mid-Morning Market Update: Markets Gain; Kroger Beats Q2 Estimates Benzinga

07:36AM EDT Biofrontera Reports Mutual Agreement With Wilhelm KT Zours, Deutsche Balaton On Key Elements Of Mediation Deal Benzinga

07:34AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company or the Biofrontera-Group), an international biopharmaceutical company, today has reached a mutual agreement with Mr. Wilhelm K.T. Zours and Deutsche Balaton AG on the key elements of a mediation agreement. The completion of the mediation agreement is expected today. GlobeNewswire Inc

Sep 9, 2020

08:00AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, will be participating virtually in two upcoming conferences. GlobeNewswire Inc

Aug 26, 2020

10:27AM EDT Biofrontera Reports H1 2020 Revs EUR 16.116M Vs EUR 13.904M YoY Benzinga

10:19AM EDT Biofrontera Halted On Volatility Benzinga

09:52AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, today published its results for the first six months ended June 30, 2020. In addition, the Company provided an overview of the current business performance. GlobeNewswire Inc

04:07AM EDT Earnings Scheduled For August 26, 2020 Benzinga

Aug 21, 2020

10:21AM EDT Biofrontera Shares Resume Trading, Move Lower; Shares Up 20% For The Session Benzinga

10:09AM EDT Biofrontera Shares Up 15%; Earlier 6K Announced Successful Placement Of 1% Qualified Subordinated Mandatory Convertible Bond 2020/2021 Benzinga

10:07AM EDT Biofrontera Shares Halted On Volatility Benzinga

Aug 20, 2020

01:00PM EDT Admission to trading of Biofronteras 1.00% GlobeNewswire Inc

Aug 19, 2020

04:30AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company), an international biopharmaceutical company, will be releasing its financial results for the first six months ended June 30, 2020 on Wednesday, August 26, 2020. GlobeNewswire Inc

Aug 18, 2020

05:00AM EDT Capital measure oversubscribed: Placement of the 1.00 % qualified GlobeNewswire Inc

Aug 14, 2020

09:36AM EDT Biofrontera Shares Halted On Volatility; Shares Down 19% Benzinga

Aug 13, 2020

04:50PM EDT Result of the subscription of the 1.00 % qualified subordinated GlobeNewswire Inc

Aug 12, 2020

10:20AM EDT Mid-Morning Market Update: Markets Open Higher; Brinker Reports Mixed Q4 Results Benzinga

09:57AM EDT Biofrontera Halted On Volatility Benzinga

Aug 11, 2020

02:05PM EDT Biofrontera Shares Halted On Multiple Circuit Breakers On Volatility; Shares Now Up 113% For The Session Benzinga

12:51PM EDT Biofrontera Shares Resume Trading, Immediately Halted On Volatility; Shares Up 116% For The Session Benzinga

12:40PM EDT Biofrontera Shares Halted On Volatility, 4th Circuit Breaker Today; Shares Up 75% For The Session Benzinga

12:30PM EDT Biofrontera Halted On Volatility, Third Time Today; Shares Up 39.7% Benzinga

12:29PM EDT Biofrontera Halted On Volatility, Third Time Today Benzinga

12:24PM EDT Biofrontera Shares Halted On Volatility Benzinga

Aug 10, 2020

10:00AM EDT Biofrontera AG announces subscription price for 1.00 % qualified GlobeNewswire Inc

Aug 6, 2020

10:13AM EDT Mid-Morning Market Update: Markets Edge Higher; Bristol-Myers Squibb Earnings Top Estimates Benzinga

07:57AM EDT The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO Benzinga

Jul 27, 2020

01:15PM EDT The Management Board of Biofrontera AG (NASDAQ ticker symbol: BFRA, ISIN: DE0006046113), today resolved, with the approval of the Supervisory Board, to issue a qualified subordinated mandatory convertible bond subject to the granting of statutory subscription rights. GlobeNewswire Inc

Jul 23, 2020

08:30AM EDT The Supervisory Board of Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today announced that the appointments and service contracts of both members of the Management Board, CEO Prof. Dr. Hermann Lbbert and CFO Thomas Schaffer, have each been extended for an additional 2 year-term. GlobeNewswire Inc

Jul 14, 2020

06:16AM EDT Biofrontera Sees Prelim. 1H Sales Benzinga

06:08AM EDT Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the Company or the Biofrontera-Group), an international biopharmaceutical company, today reports preliminary unaudited revenue for the first six months of fiscal year 2020. GlobeNewswire Inc

Share